Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Randomized Double Blinded Placebo Cross-over Study in the Pediatric Pain Population

NCT03055767 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT03055767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Randomized Double Blinded Placebo Cross-over Study in the Pediatric Pain Population
Lead sponsor
University of California, Irvine
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2017
Completion date
April 20, 2020
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

headache, migraine, migraine disorders, pediatrics